Perthera, Inc., and Hope for Stomach Cancer to educate and provide benefits of precision medicine for no cost to stomach cancer patients
News provided by: Perthera, Inc.
Feb. 14, 2017
Perthera, Inc., a McLean, VA-based precision medicine company, announced its partnership with Hope for Stomach Cancer, a patient-focused 501(C)(3) nonprofit that provides support, resources, and awareness to those facing stomach cancer. Perthera's Precision Cancer Analysis (PCA) service will be available to all Hope for Stomach Cancer patients at no cost to them.
"We're hopeful that through this new program, stomach cancer patients can get a PCA so they can be treated with precision drugs more often," said Aki Smith, founder of Hope for Stomach Cancer.
PCA is a comprehensive molecular analysis of a patient's tumor, which leverages the expertise of various medical specialists, who work as partners on the patient's cancer care team. Each patient's biological makeup is examined against Perthera's proprietary databank, as well as by cancer specialists on Perthera's Virtual Molecular Tumor Board.
"Now more than ever, having detailed knowledge about the tumor's characteristics is critical in determining the patient's most effective treatment options, and this collaboration makes that a reality, regardless of the patient's geographical location," continued Smith.
Over the past several months, Perthera has built a relationship with Smith and her organization.
"We're very impressed with the way she founded the organization, how she's growing it, and her aggressive vision for the future. Hope for Stomach Cancer's program is another sign that precision medicine is morphing from its emerging technology stage into a very real and powerful cancer treatment component," said Andrew Mignatti, CEO, and president of Perthera.
In September 2016, Perthera and Hope for Stomach Cancer co-presented a web-based presentation on precision medicine and stomach cancer, led by Dr. Michael Pishvaian, Chief Medical Officer of Perthera. Following the well-attended conference, several stomach cancer patients began actively pursuing more information about Perthera's process.
Perthera also has relationships with the Pancreatic Cancer Action Alliance (PanCAN) and the Lung Cancer Alliance (LungMATCH). These partnerships help Perthera educate cancer patients about the benefits of precision medicine.
"While a patient's genomic makeup is a very significant part of the precision medicine analysis, it is hardly enough. For example, in addition to genomic analysis, patients who use the Hope for Stomach Cancer program will have proteomic testing so that protein level and protein activation level changes, which are often more relevant to treatment response, can be identified," continued Mignatti.
Learn more about this program at www.StoCan.org
ABOUT PERTHERA, INC.: Perthera is a founder- and growth fund-backed company founded in 2012 and based in McLean, VA, that has touched thousands of lives as it provides precision medicine benefits to cancer patients, their loved ones, and the entire cancer care ecosystem. Perthera leverages biological, computational and human information and expertise, through a growing family of integrated products and services. This currently includes: the Perthera Precision Cancer Analysis (PCA), the Perthera Precision Cancer Registry, the Perthera Precision Cancer Advocacy Services, the Perthera Precision Cancer Platform, the Perthera Precision Medicine Professional Services, and the Perthera Precision Medicine Pharmaceutical Services. Click on the links to learn more.
ABOUT HOPE FOR STOMACH CANCER: Hope for Stomach Cancer, a Los Angeles-based 501(C)(3), was founded by Aki Smith in December 2013 following her father's diagnosis of advanced-stage stomach cancer. Hope for Stomach Cancer provides resources to patients, care-givers, and loved ones while promoting early detection and prevention to the public and medical communities. "Hope" creates and facilitates programs that enable those affected by stomach cancer to take actionable steps and overcome each phase of this disease.
If you would like more information about Perthera, please contact Doug Poretz at 703-408-1880 or email at firstname.lastname@example.org.
If you would like more information about Hope for Stomach Cancer, please contact Aki Smith, at 424-239-9943 or email at email@example.com.
SOURCE: Perthera, Inc.
FOR IMMEDIATE RELEASE
ABOUT HOPE FOR STOMACH CANCER: Hope for Stomach Cancer, a Los Angeles-based 501(C)(3), provides resources to patients, care-givers and loved ones while promoting early detection and prevention to the general and medical communities. “Hope” creates and facilitates programs that enable those affected by stomach cancer to take actionable steps and overcome each phase of the disease.
Twenty organizations unite to raise awareness, provide education and advocate for gastrointestinal cancers
LOS ANGELES (JUNE 6, 2016) — Hope For Stomach Cancer joins 19 other cancer advocacy groups from around the United States to form the GI Cancers Alliance, committed to the fight against gastrointestinal cancers, which include many of the leading cancer killers.
The mission of the GI Cancers Alliance is to raise awareness, provide education and advocate for the prevention, treatment and cure of gastrointestinal cancers through a collaboration of advocacy groups, industry and institutional partners.
The groups’ organizers have come together because of a shared goal to create a stronger more unified voice in the fight against gastrointestinal cancers.
“Even though stomach cancer is considered rare in the United States, with less than 27,000 new diagnoses a year, as an alliance we are talking about over 300,000 people being affected by a gastrointestinal cancer and that’s a problem,” says Aki Smith, Founder and CEO of Hope For Stomach Cancer.
The groups’ leadership met June 4 during the ASCO Annual Meeting in Chicago to elect its chairs: John Hopper, executive director of the Fibrolamellar Cancer Foundation, and board director of the National Pancreas Foundation; and Martha Raymond, executive director of Michael’s Mission and founder/CEO of The Raymond Foundation and Alliance co-chair.
In addition to Hope for Stomach Cancer, the 19 other organizations of the Alliance include: Pancreatic Cancer Action Network, Colon Cancer Alliance, Prevent Cancer Foundation, Beat Liver Tumors, The Bili Project Foundation, The Cholangiocarcinoma Foundation, Colon Cancer Challenge, Debbie’s Dream Foundation: Curing Stomach Cancer, Esophageal Cancer Action Network, Fibrolamellar Cancer Foundation, Fight Colorectal Cancer, Gastric Cancer Foundation, Global Liver Institute, Michael’s Mission, National Pancreas Foundation, No Stomach for Cancer, The Raymond Foundation, The Ruesch Center for the Cure of GI Cancers, and Target Cancer Foundation.
The participating groups represent the various types of cancers that make up gastrointestinal cancers, or the group of cancers that affect the digestive system. This includes cancers of the esophagus, gallbladder, bile duct, liver, pancreas, stomach, small intestine, bowel (large intestine or colon and rectum) and anus.
Lilly Oncology and Taiho Oncology are the founding industry non-voting members of the GI Cancers Alliance. They provide funding for advocacy activities and education.
The Alliance will focus on creating programs to raise general awareness about GI cancers and create resources and tools that will fill gaps for patients where they can make the largest impact.
Join us and help spread hope for those affected by stomach cancer!
By signing up, you will receive periodic email communication from the Stomach Cancer Awareness Network.